| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |